ERIS Lifesciences Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹873.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 15.42 per cent from ₹756.56 crore. This corresponds to a year-on-year *(YoY) growth of 12.97 per cent.
Operating Profit
Operating Profit stands at ₹295.82 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.61 per cent from ₹272.37 crore. This corresponds to a year-on-year *(YoY) growth of 6.91 per cent.
PBDT
PBDT stands at ₹251.56 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.86 per cent from ₹228.98 crore. This corresponds to a year-on-year *(YoY) growth of 8.61 per cent.
Profit Before Tax
Profit Before Tax stands at ₹179.49 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.60 per cent from ₹159.41 crore. This corresponds to a year-on-year *(YoY) growth of 11.42 per cent.
Net Profit
Net Profit stands at ₹143.32 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 48.65 per cent from ₹279.10 crore. This represents a 14.56 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
ERIS Lifesciences Ltd Earnings
- YOY
- QOQ
ERIS Lifesciences Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
ERIS Lifesciences Ltd Research Reports
ERIS Lifesciences Ltd Financial Reports
ERIS Lifesciences Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| ERIS Lifescience | 0.76% | 1.54% | -3.86% | 1.39% | -5.01% | -19.06% |
| Granules India | -2.00% | 3.57% | -4.74% | 13.04% | 47.74% | 93.88% |
| Astrazeneca Phar | -1.00% | -0.83% | -2.00% | -5.07% | -10.64% | -7.80% |
| Caplin Point Lab | 1.82% | 2.01% | 0.19% | 41.46% | 50.09% | 24.35% |
| OneSource Speci. | -0.53% | 2.35% | -6.08% | -12.87% | 31.62% | -17.15% |
| Cohance Life | 0.31% | 5.15% | -0.53% | -6.59% | 25.93% | -52.50% |
| Alivus Life | 3.42% | 2.76% | 18.73% | 22.02% | 47.29% | 48.58% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : Amit Indubhushan Bakshi
WTD & Executive Director : Kaushal Kamlesh Shah
WTD & Executive Director : Inderjeet Singh Negi
Executive Director / WTD / Chief Operating Officer : Krishnakumar Vaidyanathan
Independent Non Exe. Director : Prashant Gupta
Independent Non Exe. Director : Rajeev Narotam Dalal
Independent Non Exe. Director : Kalpana Unadkat
Independent Non Exe. Director : Sujesh Vasudevan
Company Sec. & Compli. Officer : Milind Talegaonkar
Additional Director : Vineet Varma